Caris Life Sciences
Delivers tissue and blood molecular profiling for oncology care and biopharma research.
$25.63
After-hours close−0.01 (−0.03%)
At close$25.64(−2.82%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.03 | — | — |
| Aug 2026 | $0.01 | $0.00 | −139.2% |
| May 2026 | −$0.02 | $0.00 | +92.5% |
| Feb 2026 | −$0.02 | $0.28 | +1,500.0% |
| Nov 2025 | −$0.08 | $0.08 | +200.0% |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | |||
| Aug 2025 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | $0.03 | — | — | $255.5M | — | — |
| Aug 5, 2026 | $0.01 | $0.00 | −139.2% | $238.1M | $263.7M | +10.8% |
| May 7, 2026 | −$0.02 | $0.00 | +92.5% | $209.4M | $216.2M | +3.2% |
| Feb 26, 2026 | −$0.02 | $0.28 | +1,500.0% | $240.4M | $292.9M | +21.8% |
| Nov 5, 2025 | −$0.08 | $0.08 | +200.0% | $280.9M | $216.8M | −22.8% |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||